Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

791 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysis.
Renehan AG, Solomon M, Zwahlen M, Morjaria R, Whatmore A, Audí L, Binder G, Blum W, Bougnères P, Santos CD, Carrascosa A, Hokken-Koelega A, Jorge A, Mullis PE, Tauber M, Patel L, Clayton PE. Renehan AG, et al. Among authors: jorge a. Am J Epidemiol. 2012 May 1;175(9):867-77. doi: 10.1093/aje/kwr408. Epub 2012 Apr 10. Am J Epidemiol. 2012. PMID: 22494952 Free article. Review.
A Genome-Wide Pharmacogenetic Study of Growth Hormone Responsiveness.
Dauber A, Meng Y, Audi L, Vedantam S, Weaver B, Carrascosa A, Albertsson-Wikland K, Ranke MB, Jorge AAL, Cara J, Wajnrajch MP, Lindberg A, Camacho-Hübner C, Hirschhorn JN. Dauber A, et al. Among authors: jorge aal. J Clin Endocrinol Metab. 2020 Oct 1;105(10):3203-14. doi: 10.1210/clinem/dgaa443. J Clin Endocrinol Metab. 2020. PMID: 32652002 Free PMC article.
The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
Costalonga EF, Antonini SR, Guerra-Junior G, Mendonca BB, Arnhold IJ, Jorge AA. Costalonga EF, et al. Among authors: jorge aa. J Clin Endocrinol Metab. 2009 Feb;94(2):588-95. doi: 10.1210/jc.2008-1608. Epub 2008 Nov 4. J Clin Endocrinol Metab. 2009. PMID: 18984657 Clinical Trial.
Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and -202 A/C IGFBP3 variants on treatment outcomes of children with severe GH deficiency.
Costalonga EF, Antonini SR, Guerra G Jr, Coletta RR, Franca MM, Braz AF, Mendonca BB, Arnhold IJ, Jorge AA. Costalonga EF, et al. Among authors: jorge aa. Pharmacogenomics J. 2012 Oct;12(5):439-45. doi: 10.1038/tpj.2011.13. Epub 2011 Apr 5. Pharmacogenomics J. 2012. PMID: 21468024
Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF, Costalonga EF, Trarbach EB, Scalco RC, Malaquias AC, Guerra-Junior G, Antonini SR, Mendonca BB, Arnhold IJ, Jorge AA. Braz AF, et al. Among authors: jorge aa. J Clin Endocrinol Metab. 2014 Sep;99(9):E1808-13. doi: 10.1210/jc.2014-1744. Epub 2014 Jun 6. J Clin Endocrinol Metab. 2014. PMID: 24905066
Growth hormone therapy in children; research and practice - A review.
Collett-Solberg PF, Jorge AAL, Boguszewski MCS, Miller BS, Choong CSY, Cohen P, Hoffman AR, Luo X, Radovick S, Saenger P. Collett-Solberg PF, et al. Among authors: jorge aal. Growth Horm IGF Res. 2019 Feb;44:20-32. doi: 10.1016/j.ghir.2018.12.004. Epub 2018 Dec 26. Growth Horm IGF Res. 2019. PMID: 30605792 Review.
791 results